title: Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru.
authors.affiliation: Department of Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
authors.forename: Brady E
authors.initials: BE
authors.lastname: Beltrán
authors.forename: Iván
authors.initials: I
authors.lastname: Maza
authors.forename: Celia B
authors.initials: CB
authors.lastname: Moisés-Alfaro
authors.forename: Liliana
authors.initials: L
authors.lastname: Vasquez
authors.forename: Pilar
authors.initials: P
authors.lastname: Quiñones
authors.forename: Domingo
authors.initials: D
authors.lastname: Morales
authors.forename: Gadwin
authors.initials: G
authors.lastname: Sánchez
authors.forename: Gloria
authors.initials: G
authors.lastname: Paredes
authors.forename: Mónica
authors.initials: M
authors.lastname: Oscanoa
authors.forename: Jenny
authors.initials: J
authors.lastname: Gerónimo
authors.forename: Roberto N
authors.initials: RN
authors.lastname: Miranda
authors.forename: Jorge J
authors.initials: JJ
authors.lastname: Castillo
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D006837:Hydroa Vacciniforme; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010568:Peru; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide